Cognex Corporation (NASDAQ:CGNX – Get Free Report) announced a quarterly dividend on Wednesday, May 6th. Shareholders of record on Thursday, May 21st will be paid a dividend of 0.085 per share by the scientific and technical instruments company on Thursday, June 4th. This represents a c) dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend is Thursday, May 21st.
Cognex has decreased its dividend by an average of 0.3%annually over the last three years and has increased its dividend every year for the last 10 years. Cognex has a dividend payout ratio of 31.5% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Cognex to earn $1.22 per share next year, which means the company should continue to be able to cover its $0.34 annual dividend with an expected future payout ratio of 27.9%.
Cognex Stock Performance
Shares of Cognex stock opened at $66.13 on Friday. Cognex has a 52 week low of $28.56 and a 52 week high of $71.90. The stock has a 50 day moving average price of $52.67 and a two-hundred day moving average price of $45.20. The stock has a market capitalization of $11.04 billion, a PE ratio of 78.72 and a beta of 1.48.
Insider Buying and Selling
In related news, Director Angelos Papadimitriou sold 4,150 shares of Cognex stock in a transaction on Monday, February 23rd. The stock was sold at an average price of $55.58, for a total transaction of $230,657.00. Following the sale, the director directly owned 16,222 shares in the company, valued at approximately $901,618.76. This trade represents a 20.37% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Robert Willett sold 177,052 shares of Cognex stock in a transaction on Thursday, February 12th. The stock was sold at an average price of $58.39, for a total value of $10,338,066.28. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 196,083 shares of company stock worth $11,419,321. 1.70% of the stock is owned by company insiders.
Institutional Trading of Cognex
A number of hedge funds have recently bought and sold shares of CGNX. Quent Capital LLC bought a new stake in Cognex during the third quarter worth $26,000. REAP Financial Group LLC bought a new stake in Cognex during the third quarter worth $27,000. Geneos Wealth Management Inc. lifted its holdings in Cognex by 402.2% during the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock worth $27,000 after acquiring an additional 736 shares during the period. CIBC Private Wealth Group LLC lifted its holdings in Cognex by 74.8% during the third quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company’s stock worth $35,000 after acquiring an additional 327 shares during the period. Finally, Cassaday & Co Wealth Management LLC bought a new stake in Cognex during the first quarter worth $36,000. 88.12% of the stock is currently owned by institutional investors.
About Cognex
Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.
The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.
Recommended Stories
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.
